XTX Topco’s Organogenesis Holdings ORGO Stock Holding History

XTX Topco’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,311	Closed	-$79.3K	–	4222
2025 Q4	$79.3K	Buy	+15,311	New	+$74.2K	﹤0.01%	2701
2025 Q2	–	Sell	-74,208	Closed	-$321K	–	2951
2025 Q1	$321K	Buy	74,208 +1,036	+1%	+$4.18K	0.02%	1354
2024 Q4	$234K	Buy	+73,172	New	+$246K	0.02%	1428
2024 Q2	–	Sell	-43,584	Closed	-$124K	–	2314
2024 Q1	$124K	Sell	43,584 -35,946	-45%	-$122K	0.02%	1317
2023 Q4	$325K	Buy	+79,530	New	+$223K	0.07%	557
2023 Q3	–	Sell	-98,602	Closed	-$327K	–	1890
2023 Q2	$327K	Sell	98,602 -196,498	-67%	-$581K	0.06%	651
2023 Q1	$629K	Buy	295,100 +77,962	+36%	+$193K	0.13%	189
2022 Q4	$584K	Buy	217,138 +63,732	+42%	+$186K	0.12%	234
2022 Q3	$497K	Buy	+153,406	New	+$693K	0.12%	242
2022 Q2	–	Sell	-17,602	Closed	-$134K	–	1034
2022 Q1	$134K	Buy	+17,602	New	+$136K	0.06%	474

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

XTX Topco's ORGO Position: Q1 2026 in Review

XTX Topco sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 15,311 shares — an estimated $79.3K sold.

XTX Topco first reported a position in ORGO in Q1 2022 and held it in 10 quarters. The position peaked at $629K in Q1 2023. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

XTX Topco reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 15,311 Organogenesis Holdings shares in Q1 2026, an estimated $79.3K.
XTX Topco first reported a position in Organogenesis Holdings in Q1 2022 and held it in 10 quarters.
XTX Topco's Organogenesis Holdings position peaked at $629K in Q1 2023.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.